MarketInOut Stock Screener Log In | Sign Up

YD Bio Ltd

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
YD Bio Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization415.78 mln
Float14.09 mln
Earnings Date11/30/2026

Piotroski F-Score

4 / 9
Borderline

Relative Strength

60 / 100
Outperforming

Debt / Equity

0.00
Debt-free

Pre-Tax Margin

-1,393%
Severely loss-making

ROE

-445
Deeply negative

ROA

-38.42
Deeply negative

Business Description

YD Bio Limited is a Taiwan-based medical research company working to improve how serious diseases are diagnosed and treated. Its core work centers on detecting cancer through blood tests, while also exploring new therapies built on stem cells and exosomes. These efforts aim to address conditions where patients currently have few or no effective treatment options.

Key Fundamentals

EPS-0.04
ROE-445
RPS0.02
ROIC-7.33
ROA-38.42
EBITDA, mln-2.99
EV / EBITDA-143
EV / EBIT-143
Revenue, mln0.60
EV / Revenue718

Quote Details

Last 5.94
Change 0.07 (1.19%)
Open 5.99
Volume 47,346
Turnover 281,235
Average Volume 160,716

Financial Ratios

Pre-Tax Profit Margin-1,393
Current Ratio0.02
Price / Book93.17
Debt / Equity0.00
Price / Sales671

Financial Strength

Piotroski F-Score 4 / 9
Short Ratio0.40
Short % of Float1.17

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 20% 98 / 100   
1 Month -23.94% 15 / 100   
2 Months 159% 100 / 100   
6 Months 23.75% 91 / 100   
1 Year -55.14% 16 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog